Product Overview

Alternative Name: Estetrol (E4) + Progestin Combined Pill

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Oral

Duration Type: Short-acting

Description: 20mg E4 plus a progestin in an oral contraceptive.

Updated date: May 30, 2018

Vertical Tabs


Project Phase: Late Development

Project Stage: Phase II

Began discovery in: 2001

Status Details:
  • In 2012, the clinical phase II development of Estelle was completed.

Download Product Report